Harbour Trust & Investment Management’s Novo Nordisk NVO Stock Holding History

Harbour Trust & Investment Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.32M	Sell	27,637 -8,518	-24%	-$366K	0.13%	75
2026 Q1	$1.33M	Sell	36,155 -3,541	-9%	-$168K	0.14%	76
2025 Q4	$2.02M	Sell	39,696 -61,866	-61%	-$3.16M	0.21%	67
2025 Q3	$5.64M	Sell	101,562 -4,665	-4%	-$273K	0.58%	47
2025 Q2	$7.33M	Sell	106,227 -1,034	-1%	-$70.3K	0.81%	39
2025 Q1	$7.45M	Buy	107,261 +22,195	+26%	+$1.83M	0.9%	37
2024 Q4	$7.32M	Sell	85,066 -14,731	-15%	-$1.59M	0.83%	37
2024 Q3	$11.9M	Buy	99,797 +4,444	+5%	+$593K	1.35%	21
2024 Q2	$13.6M	Buy	95,353 +26,748	+39%	+$3.54M	1.62%	17
2024 Q1	$8.81M	Buy	68,605 +9,594	+16%	+$1.14M	1.11%	25
2023 Q4	$6.1M	Buy	+59,011	New	+$5.84M	0.86%	38

Other funds holding NVO

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

AIIMS

Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Harbour Trust & Investment Management's NVO Position: Q2 2026 in Review

Harbour Trust & Investment Management reduced its Novo Nordisk (NVO) stake by 24% in Q2 2026, selling an estimated $366K and leaving 27,637 shares worth $1.32M. The position accounts for 0.13% of the portfolio, ranked #75.

Harbour Trust & Investment Management first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $13.6M in Q2 2024. 580 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Harbour Trust & Investment Management held 27,637 shares of Novo Nordisk worth $1.32M as of Q2 2026.
Harbour Trust & Investment Management sold 8,518 Novo Nordisk shares in Q2 2026, an estimated $366K.
Novo Nordisk made up 0.13% of Harbour Trust & Investment Management's portfolio in Q2 2026, its #75 holding.
Harbour Trust & Investment Management first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
Harbour Trust & Investment Management's Novo Nordisk position peaked at $13.6M in Q2 2024.
580 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Harbour Trust & Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.